Our speakers

Dr. Ramesh B Byrapaneni, Managing Director, Endiya Partners | @EndiyaVC

Dr. Ramesh Byrapaneni is a Cardiologist turned Venture Capitalist. Currently he is Managing Director at Endiya Partners, a venture capital fund that invests in ideas with the potential to change the world across Technology, Healthcare and Consumer Services.As a Venture Partner of Ventureast Tenet Fund, a seed-stage VC Fund consisting of investments across technology and technology-enabled sectors, he invested and is on the boards of OneBreath and SmartRx. He has been actively involved with Nephroplus, a healthcare startup, backed by funding from Bessemer.

With significant managerial and entrepreneurial experience, Dr. Ramesh brings a passion for early stage ventures, commitment to work, business acumen and a complementary rolodex. Dr. Ramesh was Chief of Cardiology and Founder of Medwin Hospital. He served as the President of TiE Hyderabad for 4 years and one of the Founding Directors of Hyderabad Angels. He has also jumpstarted various innovative initiatives like Hyderabad 10K Run (the first to start these 10K runs in the country) and Health Awareness Promotion Project India (HAPPi) Hearts project to prevent Non-communicable diseases (NCDs).


Dr. Ramesh Byrapaneni, MD, Endiya Partners

Dr. Ramesh Byrapaneni, MD, Endiya Partners, is a cardiologist who turned into a venture capitalist, to be a part of the healthcare innovation story. At Endiya, Dr. Ramesh has led our investments in Healthtech companies- SigTuple, ekincare and cure.fit.

Prior to Endiya, at Ventureast, he invested in companies like OneBreath and SmartRx . Dr. Ramesh is also an angel investor with Nephroplus, India’s largest chain of dialysis clinics. Earlier, Dr. Ramesh was Chief of Cardiology and Founder of Medwin Hospital. He is also the Founding Director of Hyderabad Angels and has been President of TiE Hyderabad for four years.


Dr. Ramesh Byrapaneni, Venture Partner, Ventureast

Dr. Ramesh Babu MD FACC is a Venture Partner with the Ventureast Tenet Fund, a premier seed-stage VC Fund consisting of investments across technology and technology-enabled sectors. With significant managerial and entrepreneurial experience, Dr. Ramesh brings a passion for early stage ventures, commitment to work, business acumen and a complementary rolodex. Healthcare, Education, Services (Consumer as well as Business) and Government Verticals are his key sectoral strengths.

Dr. Ramesh was Chief of Cardiology and Managing Director at Medwin Hospital. He is also the President of TiE Hyderabad and one of the Founding Members of Hyderabad Angels. He has been actively involved with Nephroplus a Healthcare startup, backed by funding from Bessemer. He has also jumpstarted various innovative initiatives like Hyderabad 10K run (the first to start these 10k runs in the country) and Health Awareness Promotion Project India (HAPPi) Hearts project to prevent Non-communicable diseases (NCDs).

Dr. Ramesh has had an excellent academic career. Dr. Ramesh Babu did his postgraduation in Internal Medicine, postdoctoral fellowship in Cardiology from PGI, Chandigarh, and Interventional Cardiology Fellowship from University of Alabama, Birmingham, USA. He was adjudged the Best Outgoing Student from the University.

Not surprising then that when you ask Dr. Ramesh what he likes, pat comes the reply, ‘Working'. But that does not mean he is all work and no play. His friends believe he is a cheerful person to have around. Dr. Ramesh lives with his wife, Dr. Srinagi, a doctor again, who is as gutsy as her better half. He has two sons and a daughter, and no, they are not doctors. He encouraged them to follow their heart and find their own calling, whether law, engineering or entrepreneurship.


Dr. Rana Mehta, Executive Director – Healthcare, PricewaterhouseCoopers

Dr. Rana Mehta currently leads the Healthcare Advisory at PricewaterhouseCoopers (PwC) He has over 15 years of experience in strategizing, planning, commissioning and operations of over 50 hospitals in South Asia. He has developed customized healthcare solutions to suit client needs within political, socio economic, geographic, and demographic imperatives.

Dr. Mehta also worked for  the Apollo Hospitals Group, Asia’s largest private healthcare provider He has been instrumental in commissioning and operating the Group’s hospitals in Delhi and Colombo.

Educational Profile
Master of Hospital Administration (MHA), Tata Institute of Social Sciences, Mumbai, India.
Bachelor of Medicine, Bachelor of Surgery (MBBS), Medical College, Kolkata, India.


Dr. Ranjit Nair, Co-Founder & CEO, Germin8

Dr. Ranjit Nair is the co-founder and CEO of Germin8, a Big Data analytics company focused building products that provide action-oriented analytics from social media interactions. These analytics drive tactical and strategic decisions related to Marketing, PR, Customer Care and Sales.

Ranjit is a PhD in Computer Science from the University of Southern California where he focused on decision-making in multiagent teams. Post his doctorate, he worked as Senior Research Scientist with Honeywell Labs, developing algorithms for decision making in the face of imprecise and incomplete information.

The urge to set up a product company focused on decision making brought him back to India where he co-founded Germin8.

Ranjit is a member of CII's Committee on Knowledge Management and Business Outcomes and serves as the President of the Mumbai chapter of USC's Alumni Club. He is also an active speaker at conferences and educational institutes.


Dr. Ravi Gaur, MD & COO, Oncquest Laboratories Ltd | @oncquest_lab

Dr. Ravi Gaur, MD Pathology, is the Chief Operating Officer and Lab Director of Oncquest Laboratories, the largest Molecular Onco Pathology laboratory in India. He has 25 years plus experience in the field of Pathology and Health care management. He brought International recognition to the Indian Healthcare Industry in the form of accreditation from the College of American Pathologists (CAP – USA). Currently he operates over 23 labs, including a super specialty centre in New Delhi with over 500 collection centre’s all over India.

Dr. Gaur is a member of many expert and advisory bodies of the industry. He is a senior member of FICCI National health care Committee. He is a quality expert with vast experience of NABL processes and was one of first India based Indian to be certified as International inspector for quality audits for College of American Pathology (CAP-USA).Before joining Oncquest in 2009, Dr Gaur was heading North & East India division of Piramal and Pathnet India Ltd ( a unit of Gribbles Pathology, Australia) He has served in the Army Medical Corps for about 15 years and holds a rank of Major of Indian Army. He has recently been awarded for excellence in setting up a global standard molecular pathology lab in India by Word Wide Achievers and ASSOCCHAM.


Dr. Raviganesh Venkataraman, CEO, Cloudnine Group of Hospitals


Dr. Ravindranath Kancharla, CMD, Global Hospitals Pvt. Ltd

Dr. Ravindranath Kancharla, M.S., FRCS (Glasgow) FRCS (Edin.) founded Global Hospitals Private Ltd. and also serves as its Managing Director. Dr. Kancharla serves as Vice President of Shiridi Sai Medical Trust, Nellore. He Worked about 7 years in the United Kingdom in various positions at Darlington Memorial Hospital, Hammersmith Hospital, St. Mark's Hospital and King's College Hospital. He has performed over 15,000 Laparoscopic Operations including over 9000 Laparoscopic Gall Bladder operations.

Dr. Kancharla was Founding member and served as Treasurer of Endoscopic & Laparoscopic Surgeons of Asia, Singapore (First Indian to occupy this post). He served as Hon. Secretary of Indian Association of Gastrointestinal & Endosurgeons from 1998 to 2000. He served as Vice President of Endoscopic & Laparoscopic Surgeons of Asia, Singapore from 2001 to 2003. He served as President of Indian Association of Gastrointestinal Endosurgeons from 2000 to 2002 and President Iages from 2002 to 2004. Dr. Kancharla serves as the Chairman of the Board of Global Hospitals Private Ltd.

He serves as a Director of Institute of Laparoscopic Training Center, Hyderabad (Recognized by ELSA, Singapore). He serves as Member of St. Mark's Association, London. He is Guest Faculty of Scientific Committee member for many International meetings of Endosurgery, Laparoscopic Surgery & G1 Surgery. 


Dr. Rex Davis, MD, dunnhumby India

Dr. Rex Davis is a leading retail scientist who has spent his career exploring the phenomenon of human behaviour and decision-making within the retail environment. As a marketer, researcher, and an analyst, Rex brings over a decade of experience to dunnhumby in helping businesses better understand their customers and adopt a customer-first approach as a key growth strategy. Rex oversees the company’s Gurgaon, India office and leads the global analyst and technology teams responsible for storing and interpreting customer data and insights for clients around the world. Prior to his current role, Rex served as Vice President, Insights, USA and was responsible for leading the insights solution group, providing leadership in the development of data modeling techniques and the delivery of customer-driven implications for The Kroger Co. and consumer packaged goods (CPG) partners. Since joining the company, Rex has been instrumental in shaping innovation and best practise standards on a global scale. Prior to dunnhumby, Rex spent seven years in marketing, customer loyalty, and analytics at Coles Myer, one of Australia’s two major retailers. At Coles, as National Loyalty Manager Rex was accountable for the company’s investment in fuel, loyalty, and direct marketing. Before that as Head of Analytics, he was responsible for driving insights out of an extensive database that covered 15% of the Australian retail economy. Striving for ever-increasing levels of insight, Rex is a major asset to our India team as the team maximises the value that India brings to dunnhumby globally.


Dr. Risham Garg, Associate Professor of Law, Associate Dean, Executive Director, Centre for Transnational Commercial Law (CTCL), National Law University Delhi